Skip to main content
. 2012 May 28;14(4):604–611. doi: 10.1038/aja.2011.178

Table 1. Baseline characteristics of the two groups.

  Placebo Active treatment P
Agea (year) 53.0±8.2 53.4±7.5 0.771
Body mass indexa (kg m−2) 28.2±4.5 30.4±5.2 0.017
Waist circumstancesa (cm) 96.3±10.7 102.7±12.3 0.003
Systolic blood pressurea (mmHg) 127.9±10.4 132.5±14.6 0.053
Diastolic blood pressurea (mmHg) 81.4±6.4 84.1±7.4 0.031
Total testosteronea (nmol l−1) 9.1±1.8 8.9±2.0 0.546
SHBGa (nmol l−1) 20.9±6.9 21.6±7.0 0.567
Total AMS scorea 38.2±11.9 42.9±13.2 0.043
 Somatic subscale 15.8±5.4 17.6±5.6 0.078
 Psychological subscale 10.0±4.0 11.6±4.5 0.045
 Sexual subscale 12.4±4.3 13.7±4.4 0.092
Ethnicityb      
 Malay 15 (25.0) 16 (26.7) 0.972
 Chinese 25 (41.7) 25 (41.7)  
 Indian 17 (28.3) 17 (28.3)  
 Others 3 (5.0) 2 (3.3)  
Comorbiditiesb      
 Hypertension 20 (33.3) 29 (48.3) 0.095
 Diabetes mellitus 9 (15.0) 14 (23.3) 0.246
 Dyslipidemia 20 (33.3) 22 (36.7) 0.702
 Coronary artery disease 3 (5.0) 6 (10.0) 0.298

Abbreviations: AMS, Aging Male Symptoms; SHBG, serum hormone-binding globulin.

a

Data expressed as mean±s.d.

b

Data expressed as n (%).